CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company
Kalaris Therapeutics, Inc.
Sign in to watch- Ticker
- KLRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831971007
- Phone
- 650-249-2727
- Business address
- 400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
- Former names
- Allovir, Inc., ViraCyte, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-19 | Sinha Vikas See Remarks | Sale | −3,186 | $0.55 | $2K | 1,140,894 |
| 2024-11-19 | Miller Edward General Counsel | Sale | −432 | $0.55 | $237 | 211,499 |
| 2024-11-19 | Brainard Diana Chief Executive Officer | Sale | −8,706 | $0.55 | $5K | 723,363 |
| 2024-11-05 | Brainard Diana Chief Executive Officer | Sale | −10,609 | $0.86 | $9K | 732,069 |
| 2024-11-05 | Miller Edward General Counsel | Sale | −2,272 | $0.86 | $2K | 211,931 |
| 2024-11-05 | Hagen Brett R Chief Accounting Officer | Sale | −1,655 | $0.86 | $1K | 69,060 |
| 2024-11-05 | Sinha Vikas See Remarks | Sale | −5,136 | $0.86 | $4K | 1,144,080 |
| 2024-10-22 | Sinha Vikas See Remarks | Sale | −1,882 | $0.77 | $1K | 1,149,216 |
| 2024-10-22 | Hagen Brett R Chief Accounting Officer | Sale | −486 | $0.77 | $373 | 70,715 |
| 2024-10-22 | Miller Edward General Counsel | Sale | −766 | $0.77 | $588 | 214,203 |
| 2024-10-21 | Sinha Vikas See Remarks | Sale | −1,546 | $0.78 | $1K | 1,151,098 |
| 2024-10-21 | Hagen Brett R Chief Accounting Officer | Sale | −479 | $0.78 | $373 | 71,201 |
| 2024-10-21 | Brainard Diana Chief Executive Officer | Sale | −9,752 | $0.78 | $8K | 742,678 |
| 2024-10-21 | Miller Edward General Counsel | Sale | −635 | $0.78 | $495 | 214,969 |
| 2024-10-03 | Sinha Vikas See Remarks | Sale | −940 | $0.81 | $766 | 1,152,644 |
| 2024-10-03 | Miller Edward General Counsel | Sale | −377 | $0.81 | $307 | 215,604 |
| 2024-10-03 | Brainard Diana Chief Executive Officer | Sale | −1,493 | $0.81 | $1K | 752,430 |
| 2024-10-03 | Hagen Brett R Chief Accounting Officer | Sale | −301 | $0.81 | $245 | 71,680 |
| 2024-08-20 | Brainard Diana Chief Executive Officer | Sale | −5,390 | $0.74 | $4K | 753,923 |
| 2024-08-19 | Miller Edward General Counsel | Sale | −422 | $0.76 | $321 | 215,981 |
Page 4 of 7 · 122 trades